Affinity Asset Advisors »

Perceptive Cap Solutions Cor Cl A shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Perceptive Cap Solutions Cor Cl A shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Perceptive Cap Solutions Cor Cl A

Tip: Access up to 7 years of quarterly data

All positions including Perceptive Cap Solutions Cor Cl A held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perceptive Cap Solutions Cor Cl A by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.5M 350k 10.06

More positions owned by Affinity Asset Advisors

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Madrigal Pharmaceuticals (MDGL)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Celldex Therapeutics Com New (CLDX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Beigene Sponsored Adr (BGNE)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)

View all positions for Affinity Asset Advisors

Top funds holding Perceptive Cap Solutions Cor Cl A

VR Adviser
RA Capital Management
Commodore Capital
683 Capital Management
Shaolin Capital Management
OZ Management
Affinity Asset Advisors
Cowen And Company
Millennium Management
Kepos Capital
Point72 Asset Management
Schonfeld Strategic Advisors
Stempoint Capital
Highbridge Capital Management
Two Sigma Investments

View all funds holding Perceptive Cap Solutions Cor Cl A